Mirum Pharmaceuticals, Inc. - common stock (MIRM) Social Stream
Mirum Pharmaceuticals Inc (MIRM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Mirum Pharmaceuticals Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 22 months, MIRM's average price target has gone up $24.5.
MIRM reports an average of 193.83% for its upside potential over the past 49 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MIRM Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 26 weeks, MIRM's average broker recommendation rating improved by 0.43.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Mirum Pharmaceuticals Inc's variance in analysts' estimates is lower than -349.78% of all US stocks.
- MIRM has a higher upside potential (average analyst target price relative to current price) than 412.18% of all US stocks.
- Mirum Pharmaceuticals Inc's average analyst price target is greater than 446.99% of stocks in the small market cap category.
- In terms of how Mirum Pharmaceuticals Inc fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 319.9% of that group.
In the Pharmaceutical Products industry, MGTA, MEIP, and MBIO are the three stocks most similar to Mirum Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding MIRM using the data that counts. Try POWR Ratings for free.